美国 · 财经报刊 · Barron's
This Biotech Stock Is Up 291% From Its IPO Price. It’s On Pace for a Record Closing High.
详细摘要
CG Oncology stock is on pace for a record closing high after ‘best case’ Phase 3 trial results for its bladder cancer treatment.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.barrons.com)
